Ivermectin cancer trials

In these studies, 40-60 percent of animals treated with the ivermectin plus anti-PD1 antibody combination completely eradicated their tumors. Numerous prophylaxis trials demonstrate that regular ivermectin use leads to large reductions in transmission

2024-03-29
    Karel telefonda yönlendirme
  1. This is the first study to evaluate the anticancer effects